Previous studies showed that LAG3 expression is strongly correlated with PD-1 expression only in papillary RCC subtypes [28], indicating that blocking both LAG3 and PD-1 in RCC may alleviate the resistance to anti-PD-1 blockade. Here, LAG3 is linked to renal cell carcinoma.